We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
35 hedge funds and large institutions have $139M invested in ESSA Pharma in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
75% more funds holding
Funds holding: 20 → 35 (+15)
60% more capital invested
Capital invested by funds: $86.5M → $139M (+$52.2M)
2.53% more ownership
Funds ownership: 67.51% → 70.04% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
35
Holders Change
+15
Holders Change %
+75%
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
11
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$14.2M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$10.3M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$6.93M |
| 4 |
SCM
Sio Capital Management
New York
|
+$4.45M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.73M |
